|
Gray M.A., de Janon A., Seeler M., Heller W.T., Panoskaltsis N., Mantalaris A., Champion J.A., Intracellular Biomacromolecule Delivery by Stimuli-Responsive Protein Vesicles Loaded by Hydrophobic Ion Pairing, ACS Omega, 10, (3), 2025, p2628 - 2639, p2628-2639 ,
Journal Article,
PUBLISHED
DOI
|
|
Nicki Panoskaltsis, Athanasios Mantalaris, The promise of human bone marrow organoids for drug discovery and testing in myeloid and lymphoid cancers, Expert Opinion on Drug Discovery, 2025, p1 - 4, p1-4 ,
Journal Article,
PUBLISHED
DOI
|
|
Murnane C., Gardiner N., Crehan O., Bacon C.L., McHugh R., Gilmer J.F., Mantalaris A., Panoskaltsis N., Chimeric Antigen Receptor-T (CAR-T) Cells as " Living Drugs ": A Clinical Pharmacist Perspective, Journal of Clinical Pharmacy and Therapeutics, 2024, 2024,
Journal Article,
PUBLISHED
DOI
|
|
Mantalaris A, Panoskaltsis N, Killard F, Personalization in advanced cellular ImmunoTherapeutics: activities in Ireland., Cell & Gene Therapy Insights, 10, (11), 2024, p1645 - 1656,
Journal Article,
PUBLISHED
URL
|
|
Klontzas M.E., Vernardis S.I., Batsali A., Papadogiannis F., Panoskaltsis N., Mantalaris A., Machine Learning and Metabolomics Predict Mesenchymal Stem Cell Osteogenic Differentiation in 2D and 3D Cultures, Journal of Functional Biomaterials, 15, (12), 2024,
Journal Article,
PUBLISHED
DOI
|
|
de Janon A, Mantalaris A, Panoskaltsis N., Three-Dimensional Human Bone Marrow Organoids for the Study and Application of Normal and Abnormal Hematoimmunopoiesis., Journal of immunology (Baltimore, Md. : 1950), 210, (7), 2023, p895-904 ,
Journal Article,
PUBLISHED
DOI
|
|
Alejandro de Janon, Aashis Thapa, Fang Zhou, Ahmet F. Coskun, Athanasios Mantalaris, Douglas K. Graham, Deborah DeRyckere, Nicki Panoskaltsis, Self-Supporting Human Acute Myeloid Leukemia (AML) Bone Marrow Organoids Established from Patient-Derived Xenografts Mimic the Human AML Microenvironment, with Distinct Cytokine Kinetics Correlating with Dynamic Cell Proliferation and Metabolic Shifts, Blood, 142, (Supplement 1), 2023, p1337 - 1337, p1337-1337 ,
Journal Article,
PUBLISHED
DOI
|
|
Perl A.E., Hosono N., Montesinos P., Podoltsev N., Martinelli G., Panoskaltsis N., Recher C., Smith C.C., Levis M.J., Strickland S., Rollig C., Gross-Langenhoff M., Chou W.-C., Lee J.-H., Yokoyama H., Hasabou N., Lu Q., Tiu R.V., Altman J.K., Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib, Blood Cancer Journal, 12, (5), 2022,
Journal Article,
PUBLISHED
DOI
|
|
Allenby M.C., Okutsu N., Brailey K., Guasch J., Zhang Q., Panoskaltsis N., Mantalaris A., A Spatiotemporal Microenvironment Model to Improve Design of a Three-Dimensional Bioreactor for Red Cell Production, Tissue Engineering - Part A, 28, (1-2), 2022, p38 - 53, p38-53 ,
Journal Article,
PUBLISHED
DOI
|
|
Dennis M., Burnett A., Hills R., Thomas I., Ariti C., Severinsen M.T., Hemmaway C., Greaves P., Clark R.E., Copland M., Russell N., Kallenbach M., Culligan D., Duncan C., Krishnamurthy P., Cuthbert A., Patalappa C., Spanoudakis M., Galvani D., Berkahn I., Patton N., Pemberton L., Virchis A., Jasani P., Parker A., Arnold C., Cuthbert R., Finnega D., Nikolousis M., Pratt G., Cahalin P., Ackroyd S., Mehta P., Protheroe R., Weinkove R., Ali S., Welch E., Smith M., Spearing R., Vyas P., Campbell G., Hamblin M., Wood M., Gupta S., Westonsmith S., Pillai A., Hunter H., Rule S., Neilson R., Lush R., Rothwell K., Swe W., Chalmers I., Prahladan M., Kwan M., Lyttleton M., Hunter A., Martin A.M., Saravanamuttu K., Saif M., Tholouli E., Andrews V., Jackson S., Rajagopal R., Morrison A., Gordon W., Mitchell L., Bowen A., McGrann A., Mittal S., Panoskaltsis N., Byrne J., Das-Gupta E., Radia R., Baker B., Kilfoyle A., Knottenbelt E., Rinaldi C., Moreton P., Furby D., Jack F., Alderman C., Belsham E., Corser R., Cranfield T., Dignum H., James C., Gudgin E., Mohan M., Kampman P., Kjeldsen L., Mourek J., Nielsen O.J., Niemann C.U., Grech H., Khan A., Sampson R., Creagh D., Szabo F., Coppell J., Veale D., Kottaridis P., Fernandes S., Cullis J., Grand E., Wandroo F., Mohite U., O'Brien D., Nicholson T., Janes S., Aitchison R., Galloway M., Mathew S., Blesing N., Green S., Mamadigi R., Plews D., Chacko J., Salim R., Allameddine A., Greenfield H., Osborne D., Hodges G., Lai H.C., Carrington P., Sadik W., Yung L., Lokare A., Alvares C., Knapper S., Goodman H., Islam S., Aitchison R., Pattinson J., Pushkaran B., Heartin E., Edwards D., Seale J., A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia: results of the LI-1 trial, British Journal of Haematology, 194, (2), 2021, p298 - 308, p298-308 ,
Journal Article,
PUBLISHED
DOI
|
|
|
